Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Fooya and Moderna in...

    Fooya and Moderna in patent war over digital vaccine

    Written by Ruby Khatun Khatun Published On 2017-12-26T09:26:11+05:30  |  Updated On 26 Dec 2017 9:26 AM IST
    Fooya and Moderna in patent war over digital vaccine

    Fooya! founder and inventor of 'digital vaccine' technology Bhargav Sri Prakash has run into a trademark war with USD 5-billion pharma giant Moderna Therapeutics.


    Moderna has filed for the 'digital vaccines' trademark and the US Patent and Trademark Office (USPTO) is opening up the case for public comment.


    Talking to PTI, Silicon Valley-based Sri Prakash claimed that he submitted an abstract proposal in November 2016 and made a presentation at the Stanford University School of Medicines' Stanford Medicine X Conference on April 22 this year.


    Moderna filed for exclusive access to 'digital vaccines' trademark a month after Sri Prakash submitted the abstract.


    The Boston-based firm's first bid to patent 'digital vaccines' was rejected by the trademark attorney who cited publications on the subject by Sri Prakash's FriendsLearn, among other information.


    Moderna then filed an appeal and USPTO has now agreed to publish the firm's bid on December 26 in a gazette for public opinion.


    'Digital vaccine' expands the definition of a standard injected vaccine. It works by inducing targeted neural activity that activates the brain to induce behaviours to reduce risk.


    "We use the same evidence backed rigour of science that an injected vaccine is subject to - to prove efficacy," Sri Prakash said.


    Sri Prakash, 41, says he will challenge the Boston-based biotechnology startup Moderna Therapeutics for the patent.


    Supporting the challenge is Stanford MedX, the world's most-discussed academic medical conference - the genesis of the current flashpoint.


    "The concept of digital vaccines developed through a scientifically rigorous and evidence backed life science-based approach by the author (Sri Prakash) and his team on April 22, 2017, was very well received by the reviewers.


    "The possibility of the exclusive ownership of the trademark rights to Digital Vaccines may undermine the scientific progress and research focused development of this emerging field," Stanford University has said in a letter reviewed by PTI.


    Stanford University and Carnegie Mellon have sent letters to USPTO batting for Sri Prakash.


    "Our position is in favour of keeping 'digital vaccines' as an emerging field of science or a subcategory of vaccines," says Sri Prakash.


    On his part, Sri Prakash walked away from a string of ventures, including a hedge fund to launch FriendsLearn, and he fears that big pharma's assertion of exclusive rights over the young field of 'digital vaccines' will crowd out upcoming startups like his.


    His company, FriendsLearn, is a self-funded Indian startup behind the medical app, Fooya!. The app, scientifically validated by global medical institutions, helps children make better food choices via immersive gaming.

    Bhargav Sri Prakashdigital vaccineFooyafounderModerna Therapeuticspatentpatent warStanford MedXStanford University School of MedicinestrademarkUS Patent and Trademark OfficeUS Pharma giantUSPTO
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok